Accordingly, antifibrotic drugs that have published clinical data and are in Phase 2, Phase 3 clinical trials or marketed are summarized in this part based on the ranking results. Table 1 Drug
Aside from several drugs in early-phase clinical trials, at least 3 drug candidates are being evaluated in phase 3 studies of patients with IPF
reviewed by a HREC on this list with a certification category relevant to the phase of the trial. phase clinical trials with medicines. This includes the
meloxicam. Intravenous Tramadol in Phase 3 Clinical Trials In its first phase 3 clinical trial, intravenous (IV) tramadol has met its
This list has been reviewed and only the drugs most likely to have an phase 3 clinical trials but have not been submitted to Health Canada. There
PITT0908: Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies (Phase II-III) Type of clinical trial: Drug clinical trial. Phase: II - III.
The drug was given a fast-track approval based on the results of a phase 2 clinical trial. The company is conducting a larger phase 3 trial to confirm the treatment s benefits.
The drug was found to be well tolerated by the clinical trial First, the results of the large phase 3 clinical trial of exenatide that has
patient, with re-hypheninsertion of needle(s) (List separately The SCALE phase 3 clinical trial program of the safety and effectiveness of liraglutide
Comments